发明授权
US06994970B1 Peptides for combating the autoantibodies that are responsible for dilatative cardiomyopathy (DCM)
失效
用于对抗负责扩张性心肌病（DCM）的自身抗体的肽
- 专利标题： Peptides for combating the autoantibodies that are responsible for dilatative cardiomyopathy (DCM)
- 专利标题（中）： 用于对抗负责扩张性心肌病（DCM）的自身抗体的肽
-
申请号： US10088681申请日： 2000-09-21
-
公开(公告)号： US06994970B1公开(公告)日： 2006-02-07
- 发明人: Wolfgang Rönspeck , Rudolf Kunze , Gerd Wallukat , Manuela Dierenfeld
- 申请人： Wolfgang Rönspeck , Rudolf Kunze , Gerd Wallukat , Manuela Dierenfeld
- 申请人地址： DE Berlin
- 专利权人： Fresenius Medical Care Affina GmbH
- 当前专利权人： Fresenius Medical Care Affina GmbH
- 当前专利权人地址： DE Berlin
- 代理机构： Jacobson Holman PLLC
- 优先权： EP99118630 19990921; EP99118631 19990921
- 国际申请： PCT/EP00/09241 WO 20000921
- 国际公布： WO01/21660 WO 20010329
- 主分类号： A61K38/00
- IPC分类号： A61K38/00
摘要：
Peptides which bind auto-antibodies being in a causally pathological relationship with dilatative cardiomyopathy are described. The peptides may be bound, for example, to a solid phase. Auto-antibodies can be removed by treating blood of patients suffering from DCM with the peptides according to the invention.
信息查询
IPC分类:
